Presentation is loading. Please wait.

Presentation is loading. Please wait.

II. assessment of dyslipidemias

Similar presentations


Presentation on theme: "II. assessment of dyslipidemias"— Presentation transcript:

1 II. assessment of dyslipidemias
American Journal of Kidney Diseases  Volume 41, Pages S22-S38 (April 2003) DOI: /S (03)

2 Fig 5 Causes of death among period prevalent patients 1997–1999, treated with hemodialysis, peritoneal dialysis, or kidney transplantation. Data are from the USRDS 2001 Annual Data Report ( Abbreviations: MI, myocardial infarction; HD, heart disease. American Journal of Kidney Diseases  , S22-S38DOI: ( /S (03) )

3 Fig 6 Example demonstrating the relative contributions of VLDL and IDL remnants to non-HDL cholesterol in two hypothetical patients with normal and high triglycerides, respectively. Although both patients A and B have the same total and HDL cholesterol levels, for patient A with normal triglycerides, most of the non-HDL cholesterol is LDL. However, for Patient B with high triglycerides, much of the non-HDL cholesterol is VLDL and IDL remnants. Units are in mg/dL. To convert mg/dL to mmol/L, multiply triglycerides by and total, LDL, HDL and non-HDL cholesterol by Abbreviations: VLDL, very low-density lipoproteins; IDL, intermediate density lipoproteins; LDL, low-density lipoproteins; HDL, high-density lipoproteins. American Journal of Kidney Diseases  , S22-S38DOI: ( /S (03) )


Download ppt "II. assessment of dyslipidemias"

Similar presentations


Ads by Google